French cosmetics giant L'Oreal is in final talks to acquire the South Korean skincare business Gowoonsesang Cosmetics owned by Mibelle Group, a unit of Swiss retailer Migros, according to two sources with knowledge of the deal.
China has been the go-to excuse for disappointing result after disappointing result in the global luxury sector for nigh on two years now, and L'Oreal's has not bucked the trend. Sales in the first nine months for France's third-largest company came to €32.4 billion, which was 6% higher on a yearly basis but considerably below analysts' expectations.
L'Oréal S.A. (OTCPK:LRLCF) 9-Month Sales Conference Call October 22, 2024 12:30 PM ET Corporate Participants Eva Quiroga - Head, Investor Relations Nicolas Hieronimus - Chief Executive Officer Christophe Babule - Chief Financial Officer Conference Call Participants Guillaume Delmas - UBS Iain Simpson - Barclays Olivier Nicolai - Goldman Sachs Sarah Simon - Morgan Stanley Jeff Stent - BNP Celine Pannuti - JPMorgan Charles Scotti - Kepler Chevreux James Edwardes Jones - RBC Tom Sykes - Deutsche Bank Rob Ottenstein - Evercore Operator Welcome to the conference call regarding L'Oréal 9-Month Sales.
French cosmetics giant L'Oreal reported a rise in third quarter sales on Tuesday that missed expectations, as it became the latest European company to see weaker-than-expected demand in China.
Given its better prospects, we believe that L'Oréal stock (OTCMKTS: LRLCY) is a better pick than its peer Ulta Beauty stock (NASDAQ: ULTA). LRLCY stock trades at a higher valuation multiple of 5.2x trailing revenues, versus 1.6x for ULTA stock.
LRLCF, a premium consumer staple, has dropped considerably in share price, making it an intriguing investment opportunity due to its quality and defensive nature. The company has earnings stability, various competitive advantages, and is financially healthy. The fact that it also operates in a growing market makes it an excellent dividend growth investment candidate. LRLCF offers a safe dividend yield of 1.78% with a 10-year dividend growth CAGR of 10.2%, with growth likely to be sustained for years to come.
L'Oreal has joined Abolis Biotechnologies's 35 million euro ($38.6 million) funding round alongside speciality chemicals group Evonik , as part of a deal to develop bio-based ingredients for beauty products, the French cosmetics group said on Thursday.
Estée Lauder stock (NYSE: EL) currently trades at $92 per share, around 75% below the level seen in December 2021. In comparison, L'Oréal (OTCMKTS: LRLCY) saw its stock decline 13% over the same period.
French cosmetics company L'Oreal is to acquire a 10% stake in Swiss skin care firm Galderma from a group of major shareholders, the two companies said on Monday.
L'Oreal has announced the acquisition of a 10% stake in dermatology solutions provider Galderma Group , the French cosmetics giant said in a statement on Monday.
L'Oréal S.A. (OTCPK:LRLCF) Q2 2024 Earnings Conference Call July 31, 2024 3:00 AM ET Company Participants Eva Quiroga - Head, IR Nicolas Hieronimus - CEO Christophe Babule - CFO Laurent Schmitt - Global Head, Corporate Finance and Financial Communications Conference Call Participants Iain Simpson - Barclays Celine Pannuti - JPMorgan Bruno Monteyne - Bernstein Guillaume Delmas - UBS Charles Scotti - Kepler Olivier Nicolai - Goldman Sachs Rogerio Fujimori - Stifel Tom Sykes - Deutsche Bank Ashley Wallace - Bank of America Operator Good morning, and welcome to the L'Oréal 2024 Half Year Results Conference Call.
L'Oréal's stock price dropped due to the CEO's comments on the beauty industry and French election results. My valuation analysis shows L'Oréal is fairly valued with strong revenue growth, margins, and diversified portfolio. Despite short-term fluctuations, L'Oréal's stock is a good long-term investment due to its strong fundamentals and growth potential.